| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 48.5M | $12.20B | -2.1% | 2.744% | 0.55% |
| 5 | JPMORGAN CHASE & CO | 47.9M | $12.17B | -15.7% | 2.709% | 0.67% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 47.0M | $11.81B | +0.6% | 2.660% | 0.63% |
| 7 | MORGAN STANLEY | 38.9M | $9.79B | +2.3% | 2.202% | 0.52% |
| 8 | Capital Research Global Investors | 30.1M | $7.57B | -3.7% | 1.704% | 1.06% |
| 9 | NORGES BANK | 25.6M | $6.43B | — | 1.446% | 0.64% |
| 10 | BANK OF AMERICA CORP /DE/ | 21.2M | $5.34B | -11.3% | 1.202% | 0.34% |
| 11 | FMR LLC | 20.8M | $5.23B | -4.5% | 1.176% | 0.23% |
| 12 | NORTHERN TRUST CORP | 20.6M | $5.17B | -3.1% | 1.164% | 0.60% |
| 13 | FRANKLIN RESOURCES INC | 19.9M | $5.01B | +36.9% | 1.128% | 1.09% |
| 14 | Capital World Investors | 19.2M | $4.83B | +21.1% | 1.085% | 0.57% |
| 15 | GOLDMAN SACHS GROUP INC | 17.7M | $4.46B | +7.9% | 1.004% | 0.39% |
| 16 | Capital International Investors | 15.6M | $3.94B | +8.5% | 0.885% | 0.81% |
| 17 | UBS Group AG | 14.7M | $3.69B | -3.0% | 0.831% | 0.47% |
| 18 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | 14.3M | $3.59B | +0.8% | 0.808% | 0.65% |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 12.9M | $3.25B | -0.4% | 0.731% | 0.43% |
| 20 | Bank of New York Mellon Corp | 12.9M | $3.23B | -3.2% | 0.728% | 0.53% |
| 21 | Legal & General Group Plc | 11.5M | $2.91B | -5.0% | 0.654% | 0.61% |
| 22 | AMERIPRISE FINANCIAL INC | 11.5M | $2.90B | +4.1% | 0.652% | 0.59% |
| 23 | DEUTSCHE BANK AG\ | 10.8M | $2.71B | +13.0% | 0.610% | 0.79% |
| 24 | RAYMOND JAMES FINANCIAL INC | 10.4M | $2.62B | +8.4% | 0.589% | 0.71% |
| 25 | Amundi | 10.0M | $2.53B | -6.2% | 0.568% | 0.61% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ABBV — a direct measure of their conviction.
| 72.41% |
| +1.11 pp |
| $256.42B |
| +17% |
| Q4 2024 | 3,509 | +5.7% | 71.30% | +1.01 pp | $219.27B | 6.9% |
| Q3 2024 | 3,321 | — | 70.29% | — | $235.57B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
224 institutions opened new positions in ABBV during Q2 2026, while 109 fully exited. 3,523 added to existing positions and 304 trimmed.
ABBV institutional ownership rose by 2.15 percentage points quarter-over-quarter, with a net change of +171 holders.
The top 10 institutions account for 46.5% of all reported 13F value in ABBV, and the top 25 account for 63.5%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
AbbVie Inc. (ABBV) Institutional Ownership